Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2 Study of PT2977 for the Treatment of Von Hippel Lindau Disease-Associated Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03401788
Recruitment Status : Active, not recruiting
First Posted : January 17, 2018
Last Update Posted : June 21, 2019
Sponsor:
Information provided by (Responsible Party):
Peloton Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 1, 2020
Estimated Study Completion Date : March 1, 2023